Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 12.

Veit-Haibach, P; Schmid, D; Strobel, K; Soyka, J D; Schaefer, N G; Haerle, S K; Huber, G F; Studer, G; Seifert, Burkhardt; Hany, T F (2013). Combined PET/CT-perfusion in patients with head and neck cancers. European Radiology, 23(1):163-173.

Schaefer, N G; Veit-Haibach, P; Soyka, J D; Steinert, H C; Stahel, R A (2012). Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): Value of 18F-FDG-PET/CT. European Journal of Radiology, 81(1):e19-e25.

Veit-Haibach, P; Treyer, V; Strobel, K; Soyka, J D; Husmann, L; Schaefer, N G; Tschopp, A; Hany, T F (2010). Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdominal Imaging, 35(5):528-536.

Petrausch, U; Samaras, P; Haile, S R; Veit-Haibach, P; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schäefer, N G (2010). Risk adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first line therapy. Annals of Oncology, 21(8):1694-1698.

Petrausch, U; Samaras, P; Veit-Haibach, P; Tschopp, A; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schaefer, N G (2010). Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of Oncology, 21(5):1053-1057.

Veit-Haibach, P; Schaefer, N G; Steinert, H C; Soyka, J D; Seifert, B; Stahel, R A (2010). Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer, 67(3):311-317.

Zweifel, M; Stenner-Liewen, F; Weber, A; Samaras, P; Zaugg, K; Knuth, A; Soyka, J D (2010). Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma. Clinical Nuclear Medicine, 35(2):103-104.

Soyka, J D; Strobel, K; Veit-Haibach, P; Schaefer, N G; Schmid, D T; Tschopp, A; Hany, T F (2010). Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine. Journal of Nuclear Medicine, 51(4):507-510.

Strobel, K; Haerle, S K; Stoeckli, S J; Schrank, M; Soyka, J D; Veit-Haibach, P; Hany, T F (2009). Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with 18F-FDG-PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 36(6):919-927.

Strobel, K; Dummer, R; Steinert, H C; Baumann Conzett, K; Schad, K; Pérez Lago, M; Soyka, J D; Veit-Haibach, P; Seifert, Burkhardt; Kalff, V (2008). Chemotherapy response assessment in stage IV melanoma patients-comparison of (18)F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B. European Journal of Nuclear Medicine and Molecular Imaging, 35(10):1786-1795.

Soyka, J D; Veit-Haibach, P; Strobel, K; Breitenstein, S; Tschopp, A; Mende, K A; Lago, M P; Hany, T F (2008). Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? Journal of Nuclear Medicine, 49(3):354-361.

Strobel, K; Burger, C; Seifert, Burkhardt; Husarik, D B; Soyka, J D; Hany, T F (2007). Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. American Journal of Roentgenology, 188(5):W467-W474.

This list was generated on Sun Dec 17 18:10:54 2017 CET.